Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations
about
Generating kidney tissue from pluripotent stem cellsRecent Progress in Stem Cell Therapy for Diabetic NephropathyModeling Kidney Disease with iPS CellsCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsRegenerative medicine for the kidney: renotropic factors, renal stem/progenitor cells, and stem cell therapyPolycystic kidney disease - where gene dosage countsModelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroidsThe native TRPP2-dependent channel of murine renal primary ciliaNephron organoids derived from human pluripotent stem cells model kidney development and injuryRapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markersKidney: polycystic kidney disease.Ciliary membrane proteins traffic through the Golgi via a Rabep1/GGA1/Arl3-dependent mechanismPolycystin-1 maturation requires polycystin-2 in a dose-dependent manner.Directed differentiation of pluripotent stem cells to kidney cells.Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.Generation of nephron progenitor cells and kidney organoids from human pluripotent stem cells.The role of cilia in the pathogenesis of cystic kidney disease.Prospect for kidney bioengineering: shortcomings of the status quo.Concise Review: Patient-Derived Stem Cell Research for Monogenic Disorders.Kidney Organoids: A Translational Journey.Potential Cancer Prevention and Treatment by Silencing the Killer Cell Immunoglobulin-like Receptor Gene in Natural Killer Cells Derived from Induced Pluripotent Stem Cells.How to grow a kidney: patient-specific kidney organoids come of age.iPS cell technology: Future impact on renal care.Primary Cilia in Cystic Kidney Disease.Phosphoinositide 3-Kinase-C2α Regulates Polycystin-2 Ciliary Entry and Protects against Kidney Cyst Formation.Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiationInduced pluripotent stem cells from polycystic kidney disease patients: a novel tool to model the pathogenesis of cystic kidney disease.Concise Review: Kidney Generation with Human Pluripotent Stem Cells.Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease.CRISPR Gene Editing in the Kidney.Regenerative potential of induced pluripotent stem cells derived from patients undergoing haemodialysis in kidney regenerationEngineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
P2860
Q54844350-2FFCC1E3-546F-49E6-98C6-C8D1787E3F39Q54845896-083DE4F4-CE5A-4E42-BD90-81D81C98560CQ54898072-D8B4F4B5-0DF9-4155-8565-170323E1C2B1Q54898073-9F1E0239-1BDF-481D-917A-982BC6482C39Q54898074-60E70C9F-AEE3-43C0-8A35-65CD66A409F4Q54898075-0A99B4ED-1136-4EAD-A6F9-524A7438040CQ54898076-F0BF2BA7-5BC0-4FEF-841B-5E0D22448561
P1343
Q26739747-EA8571EB-729F-4500-AA31-B9D315460281Q26740433-DC15ACAD-91AE-4958-847C-44A221DECE2CQ26770384-9DCBB073-D305-48D6-BB32-D6AC8A5AAF7FQ26798131-B3B2E8C9-CE8F-48D4-8E65-CD0990D9597AQ26865171-08E95CE6-9297-4154-8CF3-809EBB8AF678Q27012746-9225CFC9-A23B-44A5-AD10-EBF2939050CAQ27319887-0CCEF68C-EAD2-477E-ABCF-A9D8A3480080Q28975616-B9D48200-7B56-4510-95E9-BF10905E6E2DQ29037394-1EA2A034-4D02-410A-9B51-3B13A85FA9B0Q33660638-13506BE9-319A-4080-B40E-65DFA8D448E0Q34436755-BE36C2C2-80F1-4CA2-9E24-6EC72585557CQ34541792-157FDFD6-6B01-467E-873F-9B2E8B8CCCF7Q35149861-CC7F233D-2BEC-491E-8934-B6A5436F2A66Q36969401-1EA1D67D-6AB3-4978-AB03-0BEEB1EB71B3Q36990083-D99C6C3E-6C6C-4665-AEE9-A8D44C556F97Q37613263-B2F0AC76-3C15-4F8B-80D0-45D4ED07A784Q38313036-154506A7-22CF-46E9-8EC3-E27DA3E5EE6AQ38339791-C945D046-EE51-4408-8752-7AB13AAB7841Q38557791-E2638918-7225-4579-B81C-22A7E4B3EC69Q38558317-A0D0061C-DF1F-4F49-8F80-39A9705B6983Q38790470-D6CCE5D1-9070-4C60-910F-20CD0A4C2355Q38842275-A3D8BDE4-0DA7-4D17-BC41-7C4CD69732DDQ38954677-8EF5B552-140A-4CC7-947E-28892971E991Q39242476-7E121E6A-7D87-44E5-A5C2-629505418519Q39693435-97DF9030-D15A-4D36-B820-5C854497257AQ41718616-7336C5A1-121B-46E3-95B3-75630C00BCF6Q42965497-429FBB5C-DE27-4B00-9B73-5F7CDB184600Q48133151-1E18CAC4-4EA4-4053-9F58-CF599E71F66CQ48260423-468D9271-B247-45A6-BCA8-5D49A6EC3B18Q52431223-2533D332-3F30-4C35-81E6-678564FD0E96Q57296219-73DA4F8C-D8D3-403D-ACF9-2EB34CAA2E13Q57701133-7F649807-17F1-4114-B8AE-CFE2350CF732
P2860
Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@ast
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@en
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@nl
type
label
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@ast
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@en
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@nl
prefLabel
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@ast
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@en
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@nl
P2093
P2860
P4510
P356
P1476
Reduced ciliary polycystin-2 i ...... e patients with PKD1 mutations
@en
P2093
Albert Q Lam
Benjamin S Freedman
Jamie L Sundsbak
Joseph V Bonventre
Laurence Daheron
Maoqing Wu
Peter C Harris
Rossella Iatrino
Sarah J Koon
P2860
P304
P356
10.1681/ASN.2012111089
P577
2013-09-05T00:00:00Z